Description
SITAGORA-D is a combination of Dapagliflozin and Sitagliptin Phosphate Tablets, offered by Rapid Life Drugs & Healthcare for the management of Type 2 Diabetes Mellitus. This combination brings together an SGLT2 inhibitor and a DPP-4 inhibitor to provide complementary approaches to blood glucose management when prescribed by a healthcare professional.
Brand Name: SITAGORA-D
Composition: Dapagliflozin + Sitagliptin Phosphate
Dosage Form: Tablets
Therapeutic Category: Antidiabetic Medicine
Indication: Type 2 Diabetes Mellitus
Prescription Status: Prescription Medicine
Company Name: Rapid Life Drugs & Healthcare
Dapagliflozin + Sitagliptin Tablets Manufacturer in India
Rapid Life Drugs & Healthcare is engaged in providing pharmaceutical products for various therapeutic segments. SITAGORA-D Dapagliflozin + Sitagliptin Phosphate Tablets is one of the combination formulations offered under its product portfolio for diabetes management.
The combination contains Dapagliflozin, an SGLT2 inhibitor, and Sitagliptin, a DPP-4 inhibitor. Their complementary mechanisms may help improve glycemic control in appropriate patients with Type 2 Diabetes Mellitus.
Uses of SITAGORA-D
SITAGORA-D may be prescribed for:
- Management of Type 2 Diabetes Mellitus
- Improving blood glucose control
- Supporting glycemic management along with diet and exercise
- Patients who require combination therapy with an SGLT2 inhibitor and DPP-4 inhibitor
SITAGORA-D is not intended for the treatment of Type 1 Diabetes Mellitus or diabetic ketoacidosis unless specifically directed by a qualified healthcare professional.
How Does SITAGORA-D Work?
Dapagliflozin works by inhibiting SGLT2 in the kidneys, reducing glucose reabsorption and increasing glucose elimination through urine.
Sitagliptin inhibits the DPP-4 enzyme, increasing incretin activity and supporting glucose-dependent insulin release while reducing glucagon secretion.
Together, these mechanisms provide complementary blood glucose-lowering effects.
Benefits of SITAGORA-D
- Combination of two complementary antidiabetic medicines
- Helps support better blood glucose management
- Convenient combination tablet formulation
- Can be used alongside appropriate diet and exercise
- Suitable for patients for whom combination therapy is prescribed
Dosage and Administration
The dosage of SITAGORA-D should be decided by the treating physician according to the patient’s medical condition, blood glucose levels, kidney function and other medications.
Take the medicine exactly as prescribed. Do not alter the dosage or stop treatment without consulting a healthcare professional.
Possible Side Effects
Possible side effects may include:
- Increased urination
- Genital fungal infections
- Urinary tract infections
- Dehydration
- Headache
- Upper respiratory symptoms
- Nausea or gastrointestinal discomfort
Consult a healthcare professional if side effects are severe, persistent or unusual.
Precautions
Before using SITAGORA-D, inform your doctor about your medical history and all medicines you are taking.
Special care may be required for patients with:
- Kidney problems
- Dehydration or low blood pressure
- Recurrent urinary or genital infections
- A history of pancreatitis
- Conditions that may increase the risk of diabetic ketoacidosis
Why Choose SITAGORA-D from Rapid Life Drugs & Healthcare?
Rapid Life Drugs & Healthcare focuses on providing pharmaceutical formulations across different therapeutic categories. SITAGORA-D – Dapagliflozin + Sitagliptin Phosphate Tablets is positioned as a combination formulation for Type 2 Diabetes Mellitus management.
For product-related enquiries, pharmaceutical business opportunities and availability, contact Rapid Life Drugs & Healthcare directly.
Frequently Asked Questions
What is SITAGORA-D?
SITAGORA-D is a combination tablet containing Dapagliflozin and Sitagliptin Phosphate, used for the management of Type 2 Diabetes Mellitus as prescribed by a healthcare professional.
What is the composition of SITAGORA-D?
SITAGORA-D contains Dapagliflozin + Sitagliptin Phosphate. The exact strength should be confirmed from the product packaging or approved product specification.
Who manufactures SITAGORA-D?
SITAGORA-D is offered by Rapid Life Drugs & Healthcare.
What is SITAGORA-D used for?
SITAGORA-D is used for the management of Type 2 Diabetes Mellitus when combination therapy is considered appropriate.
Is SITAGORA-D a prescription medicine?
Yes. SITAGORA-D should be taken according to the prescription and guidance of a qualified healthcare professional.
How does Dapagliflozin work?
Dapagliflozin helps lower blood glucose by reducing glucose reabsorption in the kidneys and increasing glucose excretion through urine.
How does Sitagliptin work?
Sitagliptin inhibits DPP-4, helping enhance incretin activity and support glucose-dependent insulin secretion.
